← Back to ABOS

Acumen Pharmaceuticals, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 12/08/2026Mar 2026Filed 12/05/2026Sep 2025Filed 12/11/2025Jun 2025Filed 12/08/2026Mar 2025Filed 12/05/2026Sep 2024Filed 12/11/2025Jun 2024Filed 12/08/2025Mar 2024Filed 13/05/2025
$4
−$33−$21−$26−$41−$29−$30−$21−$15
−$0.45−$0.33−$0.44−$0.68−$0.48−$0.50−$0.34−$0.25
7263616161606060

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.